Search

Contributor:

and David Eichenbaum, MD

Real-world impact of patients lost to follow-up: factors that drive nonadherence and strategies for encouraging better follow-up from patients

ARVO 2021 Coverage: NGM621 and COOG2

PEDs in HARBOR

PEDs in HARBOR

David Eichenbaum, MD

New Technology for Intravitreal Injections

New Technology for Intravitreal Injections

David A. Eichenbaum, MD

Drug Selection and Patient Outcomes in AMD

Drug Selection and Patient Outcomes in AMD

David Eichenbaum, MD

The EVA Modes for Retinectomy and Vitrectomy

The EVA Modes for Retinectomy and Vitrectomy

Colin McCannel, MD, David Eichenbaum, MD

Retina's Role in Premium IOL Patients

Retina's Role in Premium IOL Patients

David Eichenbaum, MD

Quarterly Dosing and AMD: A Cross-Trial Comparison

Quarterly Dosing and AMD: A Cross-Trial Comparison

David A. Eichenbaum, MD

Innovations in Retina: Gene Therapy

Innovations in Retina: Gene Therapy

I. Paul Singh, MD; and David Eichenbaum, MD

Dual Blockade Improves Durability for DME Treatment

Dual Blockade Improves Durability for DME Treatment

David Eichenbaum, MD

The Benefits of the TDC Cutter

The Benefits of the TDC Cutter

Colin McCannel, MD, David Eichenbaum, MD

Keeping Patients at the Center of GA Therapy: Motivating Patients, Halting Treatment, and Monitoring Progression

Keeping Patients at the Center of GA Therapy: Motivating Patients, Halting Treatment, and Monitoring Progression

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Keeping Patients at the Center of GA Therapy: Older Caretaker for Whom Driving Is Paramount

Keeping Patients at the Center of GA Therapy: Older Caretaker for Whom Driving Is Paramount

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Keeping Patients at the Center of GA Therapy: Older, Working Patient Motivated to Continue Treatment

Keeping Patients at the Center of GA Therapy: Older, Working Patient Motivated to Continue Treatment

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Keeping Patients at the Center of GA Therapy: A Young Patient with GA and Good Vision

Keeping Patients at the Center of GA Therapy: A Young Patient with GA and Good Vision

John Kitchens, MD; Margaret Chang, MD, MS; David Eichenbaum, MD; and Ferhina Ali, MD, MPH

Fact or Fiction: Are Integrin Inhibitors a Viable Strategy?

Fact or Fiction: Are Integrin Inhibitors a Viable Strategy?

Carl D. Regillo, MD, FACS, David A. Eichenbaum, MD, and Anat Loewenstein, MD, MHA

Ranibizumab in the Treatment of Extra Large PEDs: Do the Benefits Outweigh the Risks?

Ranibizumab in the Treatment of Extra Large PEDs: Do the Benefits Outweigh the Risks?

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS

Fact or Fiction: Can a Topical Formulation Reach the Retina?

Fact or Fiction: Can a Topical Formulation Reach the Retina?

Carl D. Regillo, MD, FACS, David A. Eichenbaum, MD, and Anat Loewenstein, MD, MHA

Fact or Fiction: Will Compliance Be an Issue With a Topical Drop for DR?

Fact or Fiction: Will Compliance Be an Issue With a Topical Drop for DR?

Carl D. Regillo, MD, FACS, David A. Eichenbaum, MD, and Anat Loewenstein, MD, MHA

Complications Associated with PVR Surgery: New Approaches

Complications Associated with PVR Surgery: New Approaches

David A. Eichenbaum, MD, Manish Nagpal, MS, DO, FRCS